Adaptive Biotechnologies
ADPT
#3289
Rank
A$6.80 B
Marketcap
A$42.05
Share price
-1.44%
Change (1 day)
99.04%
Change (1 year)

Market capitalization of Adaptive Biotechnologies (ADPT)

Market cap: A$6.80 Billion

As of November 2026 Adaptive Biotechnologies has a market cap of A$6.80 Billion. This makes Adaptive Biotechnologies the world's 3289th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Adaptive Biotechnologies from 2019 to 2026

End of year Market Cap

Year Marketcap Change
2026A$6.80 B82.55%
2025A$3.72 B161.78%
2024A$1.42 B36.79%
2023A$1.04 B-35.15%
2022A$1.60 B-70.61%
2021A$5.46 B-48.06%
2020A$10.51 B96.52%
2019A$5.35 B

End of Day market cap according to different sources

On Nov 18th, 2026 the market cap of Adaptive Biotechnologies was reported to be:

A$6.90 Billion
by Nasdaq info icon info icon
A$6.90 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
HCA Healthcare
HCA
A$144.14 B 2,017.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Premier
PINC
A$3.50 B-48.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Community Health Systems
CYH
A$0.34 B-95.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Select Medical Holdings
SEM
A$3.06 B-54.93%๐Ÿ‡บ๐Ÿ‡ธ USA